Uterine Corpus Carcinosarcoma

general

An aggressive, high-grade malignant tumor that arises from the uterine corpus and is composed of carcinomatous and sarcomatous elements. The vast majority of cases are malignant mixed mesodermal (Mullerian) tumors that originate from the Mullerian ducts. Exceedingly rare cases that arise from mesonephric remnants have also been described.

55

Centers

53

Active Trials

$10.5B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Uterine Corpus Carcinosarcoma(55)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.9
2
High-Volume Research Center
72.9
350.4
4
NCI Comprehensive
50.4
5
NCI Comprehensive
50.4
650.4
750.4
8
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
50.4
950.4
1050.4
1150.4
12
BC CancerVancouver, BC
50.4
13
NCI Comprehensive
14
15
NCI Comprehensive
16
NCI Comprehensive
17
NCI Comprehensive
18
19
NCI Comprehensive
20
21
22
NCI Comprehensive
23
24
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
25
26
NCI Comprehensive
27
NCI Comprehensive
28
NCI Comprehensive
29
NCI Comprehensive
30
NCI Comprehensive
31
32
NCI Comprehensive
33
34
NCI Comprehensive
35
NCI Clinical
36
37
NCI Comprehensive
38
39
40
41
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
42
43
44
45
NCI Comprehensive
46
47
48
49
50
51
52
53
54
55

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →